ZA9725B - 4,5-Dihydronaphth[1,2-c]isoxazoles and derivatives thereof - Google Patents
4,5-Dihydronaphth[1,2-c]isoxazoles and derivatives thereofInfo
- Publication number
- ZA9725B ZA9725B ZA9725A ZA9725A ZA9725B ZA 9725 B ZA9725 B ZA 9725B ZA 9725 A ZA9725 A ZA 9725A ZA 9725 A ZA9725 A ZA 9725A ZA 9725 B ZA9725 B ZA 9725B
- Authority
- ZA
- South Africa
- Prior art keywords
- dihydronaphth
- isoxazoles
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58331996A | 1996-01-05 | 1996-01-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA9725B true ZA9725B (en) | 1997-07-07 |
Family
ID=24332609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9725A ZA9725B (en) | 1996-01-05 | 1997-01-02 | 4,5-Dihydronaphth[1,2-c]isoxazoles and derivatives thereof |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0874833A1 (ja) |
JP (1) | JP3161737B2 (ja) |
KR (1) | KR100308748B1 (ja) |
CN (1) | CN1214046A (ja) |
AR (1) | AR005347A1 (ja) |
AU (1) | AU710059B2 (ja) |
BR (1) | BR9612578A (ja) |
CA (1) | CA2241845C (ja) |
HU (1) | HUP9903706A3 (ja) |
IL (1) | IL125197A0 (ja) |
NO (1) | NO983100L (ja) |
NZ (1) | NZ325587A (ja) |
WO (1) | WO1997025317A1 (ja) |
ZA (1) | ZA9725B (ja) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2420235A1 (en) * | 2000-08-21 | 2002-02-28 | Georgetown University | 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon |
ATE372342T1 (de) * | 2002-04-02 | 2007-09-15 | Janssen Pharmaceutica Nv | Substituierte aminoisoxazolinderivate und ihre verwendung als antidepressiva |
AR040967A1 (es) * | 2002-08-12 | 2005-04-27 | Janssen Pharmaceutica Nv | Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos |
DE60331160D1 (de) * | 2002-08-15 | 2010-03-18 | Janssen Pharmaceutica Nv | Kondensierte heterocyclische isoxazolinderivate und deren verwendung als antidepressiva |
EP1532155B1 (en) | 2002-08-21 | 2008-02-27 | Janssen Pharmaceutica N.V. | C6- AND C9-SUBSTITUTED CHROMENO[4,3-c]ISOXAZOLINE DERIVATIVES AND THEIR USE AS ANTI-DEPRESSANTS |
US8025859B2 (en) | 2007-05-18 | 2011-09-27 | Cesl Limited | Process for gold and silver recovery from a sulphide concentrate |
MX336881B (es) | 2009-10-29 | 2016-02-04 | Bristol Myers Squibb Co | Compuestos heterociclicos triciclicos. |
KR102482825B1 (ko) | 2016-09-02 | 2022-12-29 | 브리스톨-마이어스 스큅 컴퍼니 | 치환된 트리시클릭 헤테로시클릭 화합물 |
US11046646B2 (en) | 2017-08-09 | 2021-06-29 | Bristol-Myers Squibb Company | Alkylphenyl compounds |
US11059784B2 (en) | 2017-08-09 | 2021-07-13 | Bristol-Myers Squibb Company | Oxime ether compounds |
KR102002633B1 (ko) | 2018-07-19 | 2019-07-22 | 김태효 | 완충이격부가 구비된 논슬립 발의류 |
KR102429797B1 (ko) | 2019-12-31 | 2022-08-05 | 주식회사 제이패션 | 기능성 무재봉 덧신 및 이를 제조하는 제조방법 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2119977A1 (en) * | 1971-04-23 | 1971-12-16 | Teikoku Hormone Manufacturing Co , Ltd, Tokio | Antiphlogistic and antisecretory napththisoxazoles - from 1-hydroxyim - 2-carbonyl derivs by intramolecular condensation |
DE69021645T2 (de) * | 1989-05-19 | 1996-02-22 | Hoechst-Roussel Pharmaceuticals Inc., Somerville, N.J. | N-(aryloxyalkyl)heteroarylpiperidine und -heteroarylpiperazine, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente. |
WO1994010162A1 (en) * | 1992-10-23 | 1994-05-11 | Merck Sharp & Dohme Limited | Dopamine receptor subtype ligands |
-
1996
- 1996-12-12 WO PCT/US1996/019569 patent/WO1997025317A1/en not_active Application Discontinuation
- 1996-12-12 KR KR1019980705166A patent/KR100308748B1/ko not_active IP Right Cessation
- 1996-12-12 IL IL12519796A patent/IL125197A0/xx unknown
- 1996-12-12 NZ NZ325587A patent/NZ325587A/xx unknown
- 1996-12-12 BR BR9612578A patent/BR9612578A/pt not_active Application Discontinuation
- 1996-12-12 CN CN96180175A patent/CN1214046A/zh active Pending
- 1996-12-12 AU AU14126/97A patent/AU710059B2/en not_active Ceased
- 1996-12-12 EP EP96944274A patent/EP0874833A1/en not_active Withdrawn
- 1996-12-12 HU HU9903706A patent/HUP9903706A3/hu unknown
- 1996-12-12 JP JP52519797A patent/JP3161737B2/ja not_active Expired - Fee Related
- 1996-12-12 CA CA002241845A patent/CA2241845C/en not_active Expired - Fee Related
-
1997
- 1997-01-02 ZA ZA9725A patent/ZA9725B/xx unknown
- 1997-01-03 AR ARP970100015A patent/AR005347A1/es unknown
-
1998
- 1998-07-03 NO NO983100A patent/NO983100L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP9903706A2 (hu) | 2000-08-28 |
EP0874833A1 (en) | 1998-11-04 |
AU1412697A (en) | 1997-08-01 |
JPH11510816A (ja) | 1999-09-21 |
HUP9903706A3 (en) | 2000-09-28 |
AU710059B2 (en) | 1999-09-09 |
WO1997025317A1 (en) | 1997-07-17 |
CA2241845C (en) | 2002-10-01 |
AR005347A1 (es) | 1999-04-28 |
NO983100D0 (no) | 1998-07-03 |
IL125197A0 (en) | 1999-03-12 |
NZ325587A (en) | 1999-02-25 |
KR19990077033A (ko) | 1999-10-25 |
KR100308748B1 (ko) | 2001-12-12 |
NO983100L (no) | 1998-09-04 |
BR9612578A (pt) | 1999-07-27 |
CA2241845A1 (en) | 1997-07-17 |
JP3161737B2 (ja) | 2001-04-25 |
CN1214046A (zh) | 1999-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2319250B (en) | Derivatives of 6,8-Difluoro-7-Hydroxycoumarin | |
NZ329176A (en) | 2,5-dioxo-imidazolidine derivatives and medicaments | |
IL117859A0 (en) | Isothiazolones and their uses | |
IL120125A0 (en) | Substituted oxazolidinones their preparation and their use | |
IL121298A (en) | N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their uses | |
IL121299A0 (en) | 4-hydroxy-piperidine derivatives and their uses | |
IL111223A (en) | 3-phenylmethanoyl benzo [b] thiene derivatives and uses thereof | |
IL126968A0 (en) | Alkylaminobenzothiazole and benzoxazole derivatives | |
HUP9904032A3 (en) | 1,2,4-benzothiadiazine derivatives,their preparation and use | |
IL143095A0 (en) | 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives | |
ZA9725B (en) | 4,5-Dihydronaphth[1,2-c]isoxazoles and derivatives thereof | |
IL131645A (en) | Pyrimido ¬1,2-a¾indole derivatives and their preparation | |
HUP9900400A3 (en) | Isoxazole derivatives | |
HUP9902901A3 (en) | Substituted 1,2,3,4-tetrahydro-2-dibenzofuranamines and 2-aminocyclohepta[b]benzofurans | |
AU2405397A (en) | Thienopyridine derivatives and their use | |
HK1023124A1 (en) | Oxime derivatives and their use as fungicides | |
GB2324090B (en) | 5,6-O-alkylidene glucono-1(4)-lactones and derivatives thereof,their preparation and use | |
HRP970162A2 (en) | 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives | |
IL120285A (en) | Process for the preparation of 1,5-benzothiazepine derivatives, process for the preparation of the intermediate thereof and an intermediate thereof | |
IL113150A0 (en) | 1,2,4-triazolo [4,3-a]pyrazin-4-one derivatives and preparation thereof | |
AU2153197A (en) | Cripowellins and synthetic derivatives thereof | |
HUP9903369A3 (en) | 8(9)-dehydroestradiol derivatives | |
IL117864A0 (en) | Benzamidoxime derivatives their preparation and use | |
ZA973492B (en) | Thienopyridine derivatives and their use. | |
PL301984A1 (en) | Derivatives of 3-phenyl-5-methylisoxzaole and 4,5-dihydroisoxasole |